Sarah Jessica Parker Splits With EpiPen Maker Over Price Hike

Actress says she’s “disappointed, saddened and deeply concerned” by steep rise in cost of allergy treatment

Sarah Jessica Parker has cut her ties with EpiPen manufacturer Mylan, following widespread recent outrage over steep price hikes for the emergency allergy treatment.

In a scathing Instagram post on Thursday, “Sex and the City” alum Parker said that she was “disappointed, saddened and deeply concerned by Mylan’s actions.”

The actress previously teamed with Mylan to raise awareness for the allergic reaction anaphylaxis.

Parker noted that epinephrine auto-injectors such as the EpiPen are “vital” to her family’s healthcare, as her son suffers from a “life-threatening peanut allergy.”

Mylan has come under heavy fire of late, following reports that the cost of an EpiPen two-pack has increased dramatically in the past several years, from approximately $100 in 2007 to six times that amount currently.